ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000272862.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.037942413	Resistant
ENSG00000272862.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.046646905	Sensitive